Findings, music, and occasional reflections by Paul Woodward

Search

Sharing

Facebooktwittermail

Follow

rss

Paywalls

Frustrated by following links to articles you can’t continue reading? Learn more, here, here, and here.

Categories

Archives

Recent Posts

Pfizer-BioNTech vaccine is highly effective after one dose and can be stored in normal freezers, data shows

The Wall Street Journal reports:

The Covid-19 vaccine developed by Pfizer Inc. and BioNTech SE generates robust immunity after one dose and can be stored in ordinary freezers instead of at ultracold temperatures, according to new research and data released by the companies.

The findings provide strong arguments in favor of delaying the second dose of the two-shot vaccine, as the U.K. has done. They could also have substantial implications on vaccine policy and distribution around the world, simplifying the logistics of distributing the vaccine.

A single shot of the vaccine is 85% effective in preventing symptomatic disease 15 to 28 days after being administered, according to a peer-reviewed study conducted by the Israeli government-owned Sheba Medical Center and published in the Lancet medical journal. Pfizer and BioNTech recommend that a second dose is administered 21 days after the first.

The finding is a vindication of the approach taken by the U.K. government to delay a second dose by up to 12 weeks so it could use limited supplies to deliver a single dose to more people, and could encourage others to follow suit. Almost one-third of the U.K.’s adult population has now received at least one vaccine shot. Other authorities in parts of Canada and Europe have prioritized an initial shot, hoping they will have enough doses for a booster when needed. [Continue reading…]

Print Friendly, PDF & Email
Facebooktwittermail
rss